Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation With Paragonix SherpaPak

ASAIO Journal publishes a new clinical study illustrating that Paragonix advanced cardiac preservation technology correlates with a significant reduction in post-transplant complications and average hospital expenses compared to conventional ice…

Continue ReadingClinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation With Paragonix SherpaPak

Dec 7, 2022: Pediatric Partial Heart Transplants: An Innovative Approach to Decrease Waitlist Mortality and Organ Discards

CAMBRIDGE, MASSACHUSETTS   - Paragonix Technologies, Inc., a leader in Advanced Organ (AOP) technology, is glad to announce that we are attending the Pediatric Partial Heart Transplants: An Innovative Approach to Decrease Waitlist Mortality and Organ Discards and support the event.

Continue ReadingDec 7, 2022: Pediatric Partial Heart Transplants: An Innovative Approach to Decrease Waitlist Mortality and Organ Discards